Pharmaron CPC, Inc.

Clinical research site in Baltimore, Maryland · Pharmaron (Baltimore) Clinical Research, 800 W Baltimore St, Baltimore, MD 21201 · (240) 673-0900 · Website

3.3on Google· View on Google Maps

As of October 2026, 11 paid clinical trials are recruiting at Pharmaron CPC, Inc. in Baltimore, Maryland. Active studies at this site cover conditions such as Metastatic Colorectal Cancer (CRC), High Risk Cardiovascular Disease and Hypertension. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: October 16, 2026.

New trial at Pharmaron CPC, Inc.? We'll email you when one opens.

Recruiting clinical trials at Pharmaron CPC, Inc. (11)

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for Metastatic Colorectal Cancer (CRC)

112 locations incl. Mobile

Sponsor: Summit Therapeutics

Sex: All·Age: 18+

Code: NCT07228832·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

for High Risk Cardiovascular Disease

263 locations incl. Birmingham

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07181109·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for Breast Cancer

61 locations incl. Minneapolis

Sponsor: Olema Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07085767·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

for Transthyretin Amyloidosis With Cardiomyopathy

45 locations incl. La Jolla

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: 18 - 85

Code: NCT07052903·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for Non-Small Cell Lung Cancer

97 locations incl. Chandler

Sponsor: Summit Therapeutics

Sex: All·Age: 18+

Code: NCT06767514·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

for Transthyretin-Mediated Amyloidosis

12 locations incl. La Jolla

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: All ages

Code: NCT04561518·Recruiting·Listed Sep 2020

Apply to this trial

ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

for Acute Hepatic Porphyria

11 locations incl. Birmingham

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: 12+

Code: NCT04883905·Recruiting·Listed May 2021

Apply to this trial

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

for Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy

11 locations incl. Aurora

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: 18 - 85

Code: NCT07223203·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults

for Cryptosporidiosis

2 locations incl. Baltimore

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 50·Accepts healthy volunteers

Code: NCT07249463·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis

for Amyotrophic Lateral Sclerosis

1 location in Baltimore

Sponsor: PRG Science & Technology Co., Ltd.

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07221240·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

First-in-Human Single and Multiple Dose of HL-400

for Parkinson Disease

1 location in Baltimore

Sponsor: Highlightll Pharmaceutical (USA) LLC

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT06997484·Phase 1·Recruiting·Listed May 2025

Apply to this trial

Get new-trial alerts for Pharmaron CPC, Inc.

We'll email you whenever a new clinical trial starts recruiting at this research site in Baltimore, MD. Unsubscribe anytime.

More research sites in Baltimore

Johns Hopkins University (192 trials)
Johns Hopkins Hospital (126 trials)
Johns Hopkins University/Sidney Kimmel Cancer Center (66 trials)
University of Maryland (56 trials)
Sinai Hospital of Baltimore (48 trials)
University of Maryland Medical Center (47 trials)
University of Maryland/Greenebaum Cancer Center (43 trials)
Johns Hopkins University School of Medicine (41 trials)
Johns Hopkins (34 trials)
Kennedy Krieger Institute (31 trials)

Is this your research site?

This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.

Explore more

Paid clinical trials in Baltimore, MD · Maryland clinical trials